(10-008) Evaluation of lipid profiles in patients taking tumor necrosis factor alpha inhibitors for Inflammatory Bowel Disease
Wednesday, December 10, 2025
11:00 AM - 12:00 PM
Location: Bayside A, Level 1
Residency Program: Kaiser Foundation Health Plan of Georgia, Inc. Residency Program Type: PGY2 (Ambulatory Care Pharmacy) Residency Program Location: Georgia
